Healthcare >> Analyst Interviews >> May 6, 2002
BRIAN BAPTY joined the healthcare team at Raymond James Ltd. in
January 2000. Prior to joining Raymond James, Dr. Bapty was the
Biotechnology Analyst at Goepel McDermid. He has been an
independent bio/medical technology consultant and held positions
as officer to several publicly-traded companies. Dr. Bapty was
ranked sixth overall by Brendan Woods after less than one year as
an Analyst ' first in Credibility of Research, third in Quality
of Written Reports, and was designated by Brendan Woods as a
'rising star'. He has a BSc in Cell and Developmental Biology and
a PhD in Experimental Medicine -Nephrology from the University of
British Columbia. Profile
James?
Dr. Bapty: From top to bottom, health care and biotech in Canada
is the general coverage. In terms of integrated health
